Literature DB >> 12508141

Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.

Robert J Biggar1, Eric A Engels, Denise Whitby, Dean H Kedes, James J Goedert.   

Abstract

Tests for human herpesvirus-8 (HHV-8) often disagree on which individuals are infected. To evaluate HHV-8 antibody changes over many years, 245 homosexual men enrolled in a prospective study between 1982 and 1999 were studied. Samples collected annually were evaluated by immunofluorescence to HHV-8 latent nuclear antigen and by an ELISA for antibody against the HHV-8 lytic antigen K8.1. When positive, samples from most subjects were persistently reactive in both assays. Titers to both lytic and latent antibodies increased for many years, usually in parallel, and were higher in human immunodeficiency virus-infected men. The increasing titers and expanding epitope recognition suggest ongoing, low-grade replication of HHV-8. Use of multiple assays is important in determining prevalence in asymptomatic populations. Because persons with more advanced infections have higher antibody titers, they are easier to detect, which may skew our understanding of the epidemiology of HHV-8.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12508141     DOI: 10.1086/345866

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.

Authors:  Roberto Flores; James J Goedert
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

2.  Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.

Authors:  Emile Gogineni; Vickie Marshall; Wendell Miley; Ahmad Bayat; Denise Whitby; Joseph A Kovacs; Peter D Burbelo
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-28       Impact factor: 2.803

3.  Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA.

Authors:  Georgina L Mbisa; Wendell Miley; Christine J Gamache; William K Gillette; Dominic Esposito; Ralph Hopkins; Michael P Busch; George B Schreiber; Richard F Little; Robert Yarchoan; Betty A Ortiz-Conde; Nazzarena Labò; Denise Whitby
Journal:  J Immunol Methods       Date:  2010-03-04       Impact factor: 2.303

4.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Relationships Between Maternal Antibody Responses and Early Childhood Infection With Kaposi Sarcoma-Associated Herpesvirus.

Authors:  Lisa K Poppe; Chipepo Kankasa; Charles Wood; John T West
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

6.  EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.

Authors:  Melissa J Blumenthal; Charlotte Schutz; Graeme Meintjes; Zainab Mohamed; Marc Mendelson; Jon M Ambler; Denise Whitby; Romel D Mackelprang; Sinead Carse; Arieh A Katz; Georgia Schäfer
Journal:  Cancer Epidemiol       Date:  2018-08-31       Impact factor: 2.984

7.  Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.

Authors:  Moraima Guadalupe; Brad H Pollock; Steven Westbrook; Spencer Redding; Delia Bullock; Gregory Anstead; Brian K Agan; Vincent C Marconi; Sharon Barbieri; Vidya Sankar; Jennifer Rebeles; Yvette Flahive; John Schoolfield; Linding Wang; Xiufen Lei; Dorothy Dow; Chih-Ko Yeh; Howard Dang; Anthony J Infante; Shou-Jiang Gao
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

8.  Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe.

Authors:  Thomas B Campbell; Margaret Borok; Buxton Ndemera; Suzanne Fiorillo; Irene E White; Xing-quan Zhang; Rhoderick N Machekano; David Katzenstein; Lovemore Gwanzura
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

9.  Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area.

Authors:  Veenu Minhas; Kay L Crabtree; Ann Chao; Tendai J M'soka; Chipepo Kankasa; Marc Bulterys; Charles D Mitchell; Charles Wood
Journal:  Am J Epidemiol       Date:  2008-05-30       Impact factor: 4.897

10.  Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.

Authors:  Siobhan Sutcliffe; Edward Giovannucci; Charlotte A Gaydos; Raphael P Viscidi; Frank J Jenkins; Jonathan M Zenilman; Lisa P Jacobson; Angelo M De Marzo; Walter C Willett; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.